Blue Jet Healthcare (BOM:544009) Tariff Resilience Score: 0/10 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544009 Blue Jet Healthcare Ltd BOM:544009
66 GF Score
Price ₹584.10
GF Value ₹520.99
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Blue Jet Healthcare Tariff Resilience Score?

Blue Jet Healthcare has the Tariff Resilience Score of 0, which implies that the company might have .

Blue Jet Healthcare has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Blue Jet Healthcare might have .

Blue Jet Healthcare  (BOM:544009) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Blue Jet Healthcare Tariff Resilience Score Related Terms

BOM:544009
66GF Score
Blue Jet Healthcare Ltd BOM:544009
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?

Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued. The current stock price of ₹584.10 is trading 12.1% above its estimated GF Value™ of ₹520.99. GuruFocus considers Blue Jet Healthcare to be Modestly Overvalued.

Key valuation signals for BOM:544009:

  • Tariff Resilience Score: 0
  • GF Value™: ₹520.99 vs. price of ₹584.10 (12.1% above fair value)
  • GF Score™: 66/100 with 10 warning signs

No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blue Jet Healthcare Business Description

Other Exchanges BLUEJET:India
Address 701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, MH, IND, 400 705
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
66GF Score

Get the complete analysis for BOM:544009

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹584.10
Price
₹520.99
GF Value